While it appears that the primary adverse pathway of the earlier model also applies to nano-CeO2, the updated model proposed here also accounts for phospholipid-like additional volume loads.
Therefore, SMS prompts of antipsychotic medication show promise as a low-cost intervention, which could potentially result in large-scale clinical and economic benefits through intervening in the adverse pathway from medication non-adherence to relapse to inpatient admission [ 7- 9, 15].
It may also contribute to adverse pathways to care such as the involvement of the criminal justice system and involuntary admissions under mental health legislation [ 7].
Some evidence has been found that such adverse pathways to care may mediate the relationship between BME status and detention, but that differences are not entirely explained.
As the statin also reduced the doxorubicin-induced drop in peripheral leukocyte count (data not shown) and alleviated acute hepatotoxicity, it appears possible that lovastatin counteracts multiple adverse pathways of anthracyclines in vivo.
One of the main aims of EIS has been to engage 'hard to reach' patients, including those from BME groups, and to reduce adverse pathways to care and coercive early treatment experiences.
A greater risk of adverse pathways to, and contacts with, psychiatric services has also been shown in BME patients [ 3, 4] a source of concern to clinicians, service planners and policy makers, service users and members of the relevant minority groups.
These in vitro assays can be used to evaluate the responses of toxicity pathways [or adverse outcome pathways (AOP ], which are innate cellular signaling pathways, and would result in adverse cellular outcomes if perturbed (Adeleye et al. 2014; Bhattacharya et al. 2011; Gibb 2008).
We determined the biological effects of B[a]P on cancer metastasis and progression, explored the adverse outcome pathway, and identified the NF-κB pathway as a potential target.
Although the Adverse Outcome Pathway framework anticipates the possibility that multiple pathways may need to be defined (i.e. different pathways that can produce the same adverse human health effect), the concept is currently aligned with the mode of action approach and focuses mainly on individual chemical effects that follow a well-described pathway to produce an adverse health outcome.
Thus, the effects of these additional pathways after BPA exposure can be tested to further build an understanding of the adverse outcome pathway for BPA exposure and mammary gland cellular effects.
